BRIEF-Intelgenx and Redhill Biopharma announce marketing approval of rizaport for migraines
April 13, 2017 at 06:06 AM EDT
* Intelgenx and Redhill Biopharma announce marketing approval of rizaport(r) for migraines in Luxembourg
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|